Working… Menu

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NoCovid)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04305457
Recruitment Status : Active, not recruiting
First Posted : March 12, 2020
Last Update Posted : December 29, 2020
University of Alabama at Birmingham
Information provided by (Responsible Party):
Lorenzo Berra, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : April 1, 2021
Estimated Study Completion Date : April 1, 2022